title: Childhood malignant diseases: which is the carnitine's role?
authors.affiliation: Paediatrics Department, University Hospital of Heraklion, Crete, Greece. rogalidu@yahoo.com
authors.forename: Maria E
authors.initials: ME
authors.lastname: Rogalidou
authors.forename: Eftichia
authors.initials: E
authors.lastname: Stiakaki
authors.forename: Athanasios
authors.initials: A
authors.lastname: Evangeliou
authors.forename: Maria
authors.initials: M
authors.lastname: Kalmanti
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects / Q000627:therapeutic use; D002331:Carnitine / Q000008:administration & dosage / Q000378:metabolism*; D006801:Humans; D009369:Neoplasms / Q000188:drug therapy / Q000378:metabolism*
chemical_list: D002331:Carnitine